Inex Pharmaceuticals Conference Call Advisory - 2006 Year End Operating Results



    VANCOUVER, March 20 /CNW/ - Inex Pharmaceuticals Corporation ("INEX";
TSX:IEX) announced today that it will hold a conference call and webcast on
Wednesday March 21, 2007 at 9:00 am PST (12:00 noon EST) to discuss 2006 year
end operating results and to provide an update on developments at the Company.

    About the Conference Call
    To participate in the conference call, please dial 416-641-6115 or
1-866-542-4241. The call will be available for replay until March 28, 2007 by
calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3217983.
    The live or archived webcast can also be accessed through the Company's
website at www.inexpharm.com.

    About INEX
    INEX is a Canadian biopharmaceutical company developing and
commercializing proprietary drugs and drug delivery systems to improve the
treatment of cancer. Further information about INEX and this news release can
be found at www.inexpharm.com.

    INEX's common shares are traded on the Toronto Stock Exchange under the
trading symbol "IEX".





For further information:

For further information: Contacts for Inex Pharmaceuticals Corporation:
Investors: Ian Mortimer, Vice President, Finance and Chief Financial Officer,
Phone: (604) 419-3200; Media: Karen Cook Boas, James Hoggan & Associates Inc.,
Phone: (604) 739-7500, Email: kcook@hoggan.com

Organization Profile

Tekmira Pharmaceuticals Corporation

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890